The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver

Recent research indicates that selective NMDA receptor GluN2B subunit antagonists may become useful for the treatment of major depressive disorders. We aimed to examine in parallel the effect of the selective NMDA receptor GluN2B subunit antagonist CP-101,606 on the pituitary/serum hormone levels an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bromek, Ewa, Haduch, Anna, Rysz, Marta, Jastrzębska, Joanna, Pukło, Renata, Wójcikowska, Olga, Danek, Przemysław Jan, Daniel, Władysława Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539289/
https://www.ncbi.nlm.nih.gov/pubmed/34683936
http://dx.doi.org/10.3390/pharmaceutics13101643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539289/
https://www.ncbi.nlm.nih.gov/pubmed/34683936
http://dx.doi.org/10.3390/pharmaceutics13101643

Ejemplares similares